Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Xencor's peak revenue was $275.1M in 2021. The peak quarterly revenue was $154.0M in 2021(q4).
Xencor's revenue increased from $10.2m in 2013 to $110.5M currently. That's a 986.25% change in annual revenue.
| Fiscal year / year | Xencor revenue |
|---|---|
| 2013 | $10.2M |
| 2014 | $9.5M |
| 2015 | $27.8M |
| 2016 | $109.0M |
| 2017 | $46.2M |
| 2018 | $40.6M |
| 2019 | $156.7M |
| 2020 | $122.7M |
| 2021 | $275.1M |
| 2022 | $164.6M |
| 2023 | $174.6M |
| 2024 | $110.5M |
How accurately did Xencor's revenue projections match actual performance?
Xencor saw the greatest revenue growth in 2016, when revenue increased by 292.7%.
Xencor had the lowest revenue growth in 2017, when revenue changed by -57.67%.
| Year | Xencor growth |
|---|---|
| 2014 | -6%↓ |
| 2015 | 192%↑ |
| 2016 | 293%↑ |
| 2017 | -58%↓ |
| 2018 | -12%↓ |
| 2019 | 286%↑ |
| 2020 | -22%↓ |
| 2021 | 124%↑ |
| 2022 | -40%↓ |
| 2023 | 6%↑ |
| 2024 | -37%↓ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2015 | - | $1.0M | $3.5M | $21.8M |
| 2016 | $7.3M | $66.0M | $7.8M | $27.9M |
| 2017 | $3.5M | $12.5M | - | $30.2M |
| 2018 | - | - | $29.0M | $11.6M |
| 2019 | $111.9M | $19.5M | $21.8M | $3.5M |
| 2020 | $32.4M | $13.1M | $35.4M | $41.9M |
| 2021 | $34.0M | $67.4M | $19.7M | $154.0M |
| 2022 | $85.5M | $30.2M | $27.3M | $21.6M |
| 2023 | $19.0M | $45.5M | $59.2M | $51.0M |
| 2024 | $16.0M | $23.9M | $17.8M | $70.0M |
Do you work at Xencor?
Is Xencor transparent about its revenue structure?
| Industry | Software & Services |
| Company Type | Public |
| Employees Number | 156 |
| Date Founded | 1997 |
| Headquarters | Monrovia, California |
| Number of Locations | 2 |
| Revenue | $110.5M |
| Net Income | -$55,181,000 |
| PE Ratio | -8.91 |
| Tax Rate | -0.0% |
| Market Capitalization | $2.1B |
| Total Assets | $846,266,000 |
| Ticker | XNCR |
Xencor received early financing of $12.3M on 1999-06-14.
| Series | Round size | Date |
|---|---|---|
| Series B | $12.3M | 06/1999 |
| Series C | $50M | 11/2000 |
| Series D | $10M | 05/2005 |
| Series E | $15M | 10/2007 |
| Debt Financing | $6M | 04/2009 |
| Debt Financing | $7.5M | 12/2010 |
| Series Unknown | $7.6M | 07/2013 |
| Post Ipo Equity | $25M | 11/2021 |
| Investors | Security type |
|---|---|
| Stafford Capital Partners | Series B |
| Stafford Capital Partners | Series C |
| Moore Capital Management | Series C |
| Sands Brothers Asset Management | Series C |
| Zen Investments | Series D |
| novo nordisk | Series E |
| Oxford Bioscience Partners | Series E |
| Merlin Nexus | Series E |
Xencor's top competitor, Seagen, earned an annual revenue of $2.0B.
Xencor's smallest competitor is Cerimon Pharmaceuticals with revenue of $760.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| MacroGenics | $77,691 | $150.0M | 307 | 8 |
| Seagen | $85,008 | $2.0B | 900 | - |
| AnaptysBio | $62,455 | $91.3M | 78 | 1 |
| Celldex Therapeutics | $68,878 | $7.0M | 134 | 6 |
| Sorbent Therapeutics | $45,711 | - | 31 | - |
| Apexigen | $67,317 | $4.9M | 39 | - |
| Allakos | $116,406 | $15.6M | 125 | 14 |
| Cerimon Pharmaceuticals | $65,257 | $760,000 | 4 | - |
| Atreca | $90,011 | $1.4M | 130 | - |
| Rakuten Americas | $106,462 | $920,000 | 18,364 | 40 |
Zippia gives an in-depth look into the details of Xencor, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Xencor. The employee data is based on information from people who have self-reported their past or current employments at Xencor. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Xencor. The data presented on this page does not represent the view of Xencor and its employees or that of Zippia.
Xencor may also be known as or be related to XENCOR INC, Xencor, Xencor Inc and Xencor, Inc.